Valve for the pharmaceutical industry NISOX

valve for the pharmaceutical industry
valve for the pharmaceutical industry
valve for the pharmaceutical industry
Add to favorites
Compare this product


for the pharmaceutical industry


The new GEA NiSoX-Valve technology introduces a complete change in high pressure homogenization technology. The NiSoX-Valve design optimizes different fluid dynamic effects employing the energy in the most efficient and effective way. The new NiSoX-Valve geometry facilitates a better distribution of energy inside the device. The better concentration of energy towards the middle of the valve and the effect of a modulated cloud cavitation are the most important elements that promote a more effective micronization of particles, and above all a significantly enhanced uniformity of the product. It may surprise you how many products need homogenization in their manufacturing process to make them more compatible with your daily life. Stabilization and a longer shelf life have always been among the highest priorities in many different processing industries but, especially nowadays, as lifestyles continue to change rapidly, they are becoming more and more valued. The design of the new GEA NiSoX-Valve combines mainly four factors optimizing the energy generated inside the system: Elongation stretching Continuous acceleration along the passage Radial impact at the centre of the valve Cloud cavitation phenomenon The effect of these factors on the flow is made possible only by virtue of a new mechanical configuration, the NiSoX-Valve is made up of only few active components: a deflector, a radial collider and the CCMS system (Cavitation Cloud Modulating System).


*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.